Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
TSE:4883
Price:
77 JPY
Updated:
Apr 30, 2024
Modalis Therapeutics Corp
Cash from Financing Activities
|
Modalis Therapeutics Corp
Cash from Financing Activities Peer Comparison
Comparables:
2160
4587
4974
J
7774
S
4599
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Modalis Therapeutics Corp
TSE:4883
|
Cash from Financing Activities
¥1.2B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Cash from Financing Activities
¥10.7B
|
CAGR 3-Years
137%
|
CAGR 5-Years
54%
|
CAGR 10-Years
11%
|
|
|
PeptiDream Inc
TSE:4587
|
Cash from Financing Activities
¥264.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Cash from Financing Activities
-¥5.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash from Financing Activities
-¥535k
|
CAGR 3-Years
33%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
S
|
StemRIM Inc
TSE:4599
|
Cash from Financing Activities
¥202.6m
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Cash from Financing Activities?
Cash from Financing Activities
1.2B
JPY
1.2B
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Cash from Financing Activities amounts to 1.2B JPY.
What is Modalis Therapeutics Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-24%
-24%
Over the last year, the Cash from Financing Activities growth was 1 810%. The average annual Cash from Financing Activities growth rates for Modalis Therapeutics Corp have been -24% over the past three years .
You don't have any saved screeners yet
